Nature,a rich source of bioactive natural products,serves as a massive pool of drug candidates for the pharmaceutical industry.However,the supply of these structurally complex chemicals is costly as most of the natura...Nature,a rich source of bioactive natural products,serves as a massive pool of drug candidates for the pharmaceutical industry.However,the supply of these structurally complex chemicals is costly as most of the natural products are scarce in nature,thus requiring de novo synthesis.The supply chain issue hinders the development of novel therapeutic agents from natural products.Microbial synthesis,based on the expression of biosynthetic genes in a suitable microbial host to produce certain chemicals,is a sustainable strategy to produce complex natural products.However,this strategy requires gaining insights into the biosynthesis of target molecules.Most natural products are biosynthetically unknown or not fully elucidated;thus,the sole application of microbial synthesis strategy to produce a given molecule is challenging.In this review,we highlight a strategy that combines microbial and chemical syntheses to tackle the supply chain issue in developing drugs from natural products.We believe this strategy can revive the drug development pipeline for natural products.展开更多
基金supported by the National Natural Science Foundation of China(No.82173719)the fundings from the Shenzhen Bay Laboratory(Nos.SZBL21230051 and SZBL2021080601007).
文摘Nature,a rich source of bioactive natural products,serves as a massive pool of drug candidates for the pharmaceutical industry.However,the supply of these structurally complex chemicals is costly as most of the natural products are scarce in nature,thus requiring de novo synthesis.The supply chain issue hinders the development of novel therapeutic agents from natural products.Microbial synthesis,based on the expression of biosynthetic genes in a suitable microbial host to produce certain chemicals,is a sustainable strategy to produce complex natural products.However,this strategy requires gaining insights into the biosynthesis of target molecules.Most natural products are biosynthetically unknown or not fully elucidated;thus,the sole application of microbial synthesis strategy to produce a given molecule is challenging.In this review,we highlight a strategy that combines microbial and chemical syntheses to tackle the supply chain issue in developing drugs from natural products.We believe this strategy can revive the drug development pipeline for natural products.
